A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom

PHASE2CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Meniere's Disease
Interventions
DRUG

OTO-104

DRUG

Placebo

Trial Locations (15)

Unknown

Heatherwood & Wexham Park Hospitals, Berkshire

Birmingham University Hospital, Birmingham

BMI The Edgbaston Hospital, Birmingham

Southmead Hospital Bristol, Bristol

Oxford University Hospitals, Bucks

Cambridge University Hospitals, Cambridge

Dorset County Hospital, Dorset

Gloucestershire Royal Hospital, Gloucester

Leicester Royal Infirmary, Leicestershire

Guy's Hospital and St. Thomas' Hospital, London

St. George Hospital, London

Norfolk & Norwich University Hospital, Norfolk

John Radcliffe Hospital, Oxford

Sheffield Teaching Hospitals & Sheffield Children's Hospital, Sheffield

University Hospital of North Staffordshire, Stoke-on-Trent and Stafford General Hospital, Staffordshire

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Otonomy, Inc.

INDUSTRY